Sven Gerjets Named CTO at Gap Inc. – CIO Newsby Lilu Anderson 18.06.2024"Sven Gerjets joins Gap Inc. as Chief Technology Officer, set to drive digital transformation and enhance customer engagement with his ...
7 Breakthrough Biotech Stocks to Boost Your Portfolio in 2023by Lilu Anderson 18.06.2024"Discover 7 breakthrough biotech stocks poised to boost your portfolio in a sector projected to reach $521.6B by 2033. Learn ...
PleasrDAO’s Legal Move Against Shkreli Marks Web3 Maturityby John Darbie 18.06.2024PleasrDAO sues Martin Shkreli over Wu-Tang album rights breach, highlighting the need for legal frameworks in decentralized organizations.
AI, Faith, and Ethics: Lutheran Alliance Explores Implicationsby Lilu Anderson 17.06.2024Social media buzzes with a writer's AI lament, probing ethics in AI’s personhood, usage, and impact on life and warfare, ...
Digital Twins Crucial for EV Powertrain Design Amid Growthby Lilu Anderson 17.06.2024The global electric powertrain market, valued at $83.30B in 2022, is set to grow at a 15.3% CAGR by 2030. ...
Ethereum Analysis: Price Trends Hint at Ongoing Downsideby John Darbie 16.06.2024"Cryptocurrency analysis flags caution with bearish RSI divergences, declining active addresses, and critical IOMAP insights by analyst Jake."
Bitcoin Forecast: Potential Drop to $48,000 Loomsby John Darbie 15.06.2024Bitcoin forecasts grow bleak with analysts predicting significant price drops amid slowing growth. Join 'Read to Earn' for crypto rewards.
Horizon Technology Finance Announces Monthly Dividend of $0.11by Mark Eisenberg 15.06.2024Horizon Technology Finance posts $1.32 annual dividend, yielding 11.01%. Ex-dividend date: June 17. EPS forecast: $1.48 for the year. NYSE:CX.
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stockby Mark Eisenberg 15.06.2024Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...